Zhang Zhao
FDA investigator
Appears on 2 documents from 2022 to 2023, mostly at sites in China. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 6.5
- Observations per 483
- 2022
- First seen
- 2023
- Most recent
What they cite most
From 13 observations- 21 CFR 211.100Written procedures; deviations3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.160General requirements2
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194Laboratory records1
Activity by year
2022: 1, 2023: 1
Where
China 1 · Ireland 1
Often inspects with
Is Zhang Zhao coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-12-15 | 483 Suzhou Suncadia Biopharmaceuticals Co., Ltd.Dec 15, 2023 · Suzhou, China | Suzhou, China | 10 | |
| 2022-04-08 | 483 Alexion Pharma International Operations LimitedApr 8, 2022 · Athlone, Ireland | Athlone, Ireland | 3 |
About this profile
What does Zhang Zhao inspect?
Zhang Zhao appears on 2 documents on file covering 2 sites, mostly in China.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Zhang Zhao is dated Dec 15, 2023.